CeO<sub>2</sub> Nanoparticles-Regulated Plasmid Uptake and Bioavailability for Reducing Transformation of Extracellular Antibiotic Resistance Genes

oleh: Yinuo Xu, Hao Du, Chuanxi Wang, Le Yue, Feiran Chen, Zhenyu Wang

Format: Article
Diterbitkan: MDPI AG 2023-03-01

Deskripsi

The direct uptake of extracellular DNA (eDNA) via transformation facilitates the dissemination of antibiotic resistance genes (ARGs) in the environment. CeO<sub>2</sub> nanoparticles (NPs) have potential in the regulation of conjugation-dominated ARGs propagation, whereas their effects on ARGs transformation remain largely unknown. Here, CeO<sub>2</sub> NPs at concentrations lower than 50 mg L<sup>−1</sup> have been applied to regulate the transformation of plasmid-borne ARGs to competent <i>Escherichia coli</i> (<i>E. coli</i>) cells. Three types of exposure systems were established to optimize the regulation efficiency. Pre-incubation of competent <i>E. coli</i> cells with CeO<sub>2</sub> NPs at 0.5 mg L<sup>−1</sup> inhibited the transformation (35.4%) by reducing the ROS content (0.9-fold) and cell membrane permeability (0.9-fold), thereby down-regulating the expression of genes related to DNA uptake and processing (<i>bhsA</i>, <i>ybaV</i>, and <i>nfsB</i>, 0.7–0.8 folds). Importantly, CeO<sub>2</sub> NPs exhibited an excellent binding capacity with the plasmids, decreasing the amounts of plasmids available for cellular uptake and down-regulating the gene expression of DNA uptake (<i>bhsA</i>, <i>ybaV</i>, and <i>recJ</i>, 0.6–0.7 folds). Altogether, pre-exposure of plasmids with CeO<sub>2</sub> NPs (10 and 25 mg L<sup>−1</sup>) suppressed the transformation with an efficiency of 44.5–51.6%. This study provides a nano-strategy for controlling the transformation of ARGs, improving our understanding on the mechanisms of nanomaterial-mediated ARGs propagation.